advance hearing loss therapies

Sensorion, a biotech company focused on developing novel treatments for hearing loss disorders, announced today that it has raised €50.5 million from a group of investors, including existing shareholders Redmile Group, Invus and Sofinnova Partners, and new US healthcare specialists funds. The company will issue 88.6 million new shares at €0.57 each. The funds will…